These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6375511)

  • 1. Assessment of pharmacological agents with a hemorheological action.
    Dormandy JA; Matrai A
    Ann N Y Acad Sci; 1983; 416():599-610. PubMed ID: 6375511
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
    Dettelbach HR; Aviado DM
    J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
    [No Abstract]   [Full Text] [Related]  

  • 4. The hemorheological role of cellular factors in peripheral vascular disease.
    Ciuffetti G; Mannarino E; Pasqualini L; Mercuri M; Lennie SE; Lowe GD
    Vasa; 1988; 17(3):168-70. PubMed ID: 3176641
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheological properties of human erythrocytes and their influence upon the "anomalous" viscosity of blood.
    Schmid-Schönbein H; Wells RE
    Ergeb Physiol; 1971; 63():146-219. PubMed ID: 5558776
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin and muscle flow during exercise in intermittent claudication.
    Koppelmann J
    Scand J Clin Lab Invest Suppl; 1973; 128():93-6. PubMed ID: 4764606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
    Ehrly AM; Seebens H; Saeger-Lorenz K
    Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication.
    Mashiah A; Patel P; Schraibman IG; Charlesworth D
    Br J Surg; 1978 May; 65(5):342-5. PubMed ID: 647201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological aspects of sickle cell disease.
    Klug PP; Lessin LS; Radice P
    Arch Intern Med; 1974 Apr; 133(4):577-90. PubMed ID: 4594395
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and rheological studies in patients with intermittent claudication.
    Jacobs MJ; Breslau PJ; Greep JM; Lemmens HA
    Atherosclerosis; 1985 Jun; 55(3):331-7. PubMed ID: 4015751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INFLUENCE OF FIBRINOGEN ON FLOW PROPERTIES OF ERYTHROCYTE SUSPENSIONS.
    WELLS RE; GAWRONSKI TH; COX PJ; PERERA RD
    Am J Physiol; 1964 Nov; 207():1035-40. PubMed ID: 14237445
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood rheology in arterial disease.
    Lowe GD
    Clin Sci (Lond); 1986 Aug; 71(2):137-46. PubMed ID: 3522049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemorheologic changes in patients with obliterative arteriopathy of the leg before and after muscle exercise tests].
    Bianco S; Todini AR; Fabiani F; Bartolo M
    J Mal Vasc; 1990; 15(3):291-5. PubMed ID: 2212878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rheological model for studying the hematocrit dependence of red cell-red cell and red cell-protein interactions in blood.
    Quemada D
    Biorheology; 1981; 18(3-6):501-16. PubMed ID: 7326391
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheology and hemodynamics.
    Cokelet GR
    Annu Rev Physiol; 1980; 42():311-24. PubMed ID: 6996583
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemorheology, plasma expanders, and nutritional blood flow.
    Groth CG
    Int Anesthesiol Clin; 1969; 7(2):239-60. PubMed ID: 5383767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.